Upgrade to SI Premium - Free Trial

Medtronic (MDT) Announces FDA Approval, U.S. Launch of Next Generation Pacemakers

November 20, 2017 9:02 AM
Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Comments

Next Articles